Skip to main content

Doximity, Inc. (DOCS) Stock

Doximity, Inc. Stock Details, Movements and Public Alerts

Stock Details

Doximity, Inc. (DOCS), a prominent company in the healthcare sector within the health information services industry, is based in United States and primarily trades on the NYQ.Currently, the stock is trading at $22.50. Over the past 52 weeks, it has ranged between $21.82 and $76.51. This places the current price at 29.4% of its 52-week high and 3.1% above its 52-week low. Recent trading volume was recorded at 1,922,374. The 14-day Relative Strength Index (RSI) stands at 28.80, suggesting oversold conditions. The stock is currently trading below its 50-day moving average of $27.06 by 16.85%. Similarly, it is below its 200-day moving average of $50.87 by 55.77%. The MACD histogram is 0.09, indicating bullish momentum (MACD Line: -1.24, Signal Line: -1.33). There is currently 1 active alert set for DOCS by users.

52-Week Range

$76.51 - $21.82

-70.59% from high · +3.12% from low

Avg Daily Volume

2,565,017

20-day average

100-day avg: 3,185,168

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

19.40

Near market average

Forward P/E

13.86

Earnings expected to grow

Price to Book

4.25

EV/EBITDA

13.98

EPS (TTM)

$1.16

Price to Sales

6.64

Beta

1.42

Similar volatility to market

Q:How is DOCS valued relative to its earnings and growth?
Doximity, Inc. trades at a P/E ratio of 19.40, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 13.86 is lower than the current P/E, indicating analysts expect earnings to grow over the next year.
Q:What is DOCS's risk profile compared to the market?
With a beta of 1.42, Doximity, Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 4.25 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

37.54%

Operating Margin

38.89%

EBITDA

$245.46M

Return on Equity

23.82%

Return on Assets

12.84%

Revenue Growth (YoY)

9.80%

Earnings Growth (YoY)

-16.20%

Q:How profitable and efficient is DOCS's business model?
Doximity, Inc. achieves a profit margin of 37.54%, meaning it retains $37.54 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of 38.89% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 23.82% and ROA at 12.84%, the company generates strong returns on invested capital.
Q:What are DOCS's recent growth trends?
Doximity, Inc.'s revenue grew by 9.80% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 16.20% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against Health Information Services industry averages for proper context.

Company Size & Market

Market Cap

$4.2B

Revenue (TTM)

$637.78M

Revenue/Share (TTM)

$3.40

Shares Outstanding

133.81M

Book Value/Share

$5.29

Asset Type

EQUITY

Q:What is DOCS's market capitalization and position?
Doximity, Inc. has a market capitalization of $4.2B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 133.81M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Health Information Services industry, it competes with other firms in this sector.
Q:How does DOCS's price compare to its book value?
Doximity, Inc.'s book value per share is $5.29, while the current stock price is $22.50, resulting in a price-to-book (P/B) ratio of 4.25. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$39.55

75.76% upside potential

Analyst Recommendations

Strong Buy

5

Buy

11

Hold

5

Sell

0

Strong Sell

1

Q:How reliable are analyst predictions for DOCS?
22 analysts cover DOCS with 73% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $39.55 implies 75.8% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on DOCS?
Current analyst recommendations:5 Strong Buy, 11 Buy, 5 Hold, 01 Strong Sell. The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Apr 8, 2026, 02:09 AM

Technical Indicators

RSI (14-day)

28.80

Oversold

50-Day Moving Average

$27.06

-16.85% below MA-50

200-Day Moving Average

$50.87

-55.77% below MA-200

MACD Line

-1.24

MACD Signal

-1.33

MACD Histogram

0.09

Bullish

Q:What does DOCS's RSI value tell investors?
The RSI (Relative Strength Index) for DOCS is currently 28.80, indicating the stock is in oversold territory (below 30). This indicates heavy selling pressure that may have pushed the price too low too fast. Oversold readings can present buying opportunities, but stocks can remain oversold in strong downtrends. Look for RSI to rise above 30 as a potential recovery signal. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret DOCS's MACD and moving average crossovers?
MACD analysis shows the MACD line at -1.24 above the signal line at -1.33, with histogram at 0.09. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($27.06) is below the 200-day MA ($50.87), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Apr 8, 2026, 12:32 AM

Active Alerts

Alert Condition
Price rises above
Threshold
$50.00
Created
Feb 11, 2026, 04:33 PM

Stay Ahead of the Market with Doximity, Inc. Alerts

Set up price alerts for Doximity, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.